Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enovis Corp (ENOV)
Enovis Corp stock price live, this page displays NYSE ENOV stock exchange data. View the ENOV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Enovis Corp real time stock price chart below.
What Is the Enovis Corp Stock Price Today?
The Enovis Corp stock price today is 31.44.
What Is the Stock Symbol for Enovis Corp?
The stock symbol for Enovis Corp is ""ENOV.""
What Stock Exchange Does Enovis Corp Trade On?
Enovis Corp is listed and trades on the NYSE stock exchange.
Is Enovis Corp a Good Stock to Buy?
Determining whether Enovis Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENOV quote. (ISIN: US1940145022)
What Is the Enovis Corp Stock Price Today?
The Enovis Corp stock price today is 31.44.
What Is the Stock Symbol for Enovis Corp?
The stock symbol for Enovis Corp is ""ENOV.""
What Stock Exchange Does Enovis Corp Trade On?
Enovis Corp is listed and trades on the NYSE stock exchange.
Is Enovis Corp a Good Stock to Buy?
Determining whether Enovis Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENOV quote. (ISIN: US1940145022)
NYSE
Currency in USD
Fair Value
An estimate of a Enovis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.84
31.75
52 wk Range
25.47
49.83
ENOV Scorecard
Full Analysis
Operates with a significant debt burden
ENOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Enovis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.8431.75
52 wk Range
25.4749.83
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ENOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Enovis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
52.20
Upside
+66.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Enovis Corp Company Profile
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Enovis Corp Earnings Call Summary for Q2/2025
- Enovis Q2 2025 EPS of $0.79 beat expectations by 9.92%, revenue reached $564.5M, surpassing forecasts
- Stock surged 11.94% to $27 in pre-market trading; analysts set price targets from $37 to $75
- Company raised full-year revenue guidance to $2,245-$2,275M, citing 7% YoY sales increase and new product launches
- Recon segment saw 8% organic growth; focus on debt reduction and R&D investment for future innovation
- CEO emphasized shareholder trust; CFO indicated positive outlook with raised guidance for margins and earnings
Last Updated: 07/08/2025, 18:34
Read Full TranscriptCompare ENOV to Peers and Sector
Metrics to compare | ENOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | 29.2x | −0.6x | |
PEG Ratio | 0.00 | 0.19 | 0.00 | |
Price/Book | 0.7x | 3.5x | 2.6x | |
Price / LTM Sales | 0.8x | 2.8x | 3.3x | |
Upside (Analyst Target) | 67.0% | 73.3% | 38.0% | |
Fair Value Upside | Unlock | 13.4% | 4.4% | Unlock |
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 52.20
(+66.03% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
0.79 / 0.7187
Revenue / Forecast
564.55M / 555.31M
People Also Watch
FAQ
What Stock Exchange Does Enovis Trade On?
Enovis is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Enovis?
The stock symbol for Enovis is "ENOV."
What Is the Enovis Market Cap?
As of today, Enovis market cap is 1.81B.
What Is Enovis's Earnings Per Share (TTM)?
The Enovis EPS (TTM) is -14.72.
When Is the Next Enovis Earnings Date?
Enovis will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is ENOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Enovis Stock Split?
Enovis has split 1 times.
How Many Employees Does Enovis Have?
Enovis has 7367 employees.
What is the current trading status of Enovis (ENOV)?
As of 24 Aug 2025, Enovis (ENOV) is trading at a price of 31.44, with a previous close of 29.50. The stock has fluctuated within a day range of 29.84 to 31.75, while its 52-week range spans from 25.47 to 49.83.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.